Earnings
ICDX
1.300
0.00%
--
Currencies: USD
Items
Total Revenue
Revenue
Other Revenue, Total
Cost of Revenue, Total
Gross Profit
Operating Expense
Selling/General/Admin.Expenses,Total
Research & Development
Depreciation/Amortization
Interest Exp.(Inc.), Net-Operating, Total
Unusual Expense (Income)
Other Operating Expenses, Total
Operating Income
Interest Inc.(Exp.),Net-Non-Op.,Total
Gain(Loss) on Sale of Assets
Other, Net
Net Income Before Taxes
Provision for Income Taxes
Net Income After Taxes
Minority Interest
Equity in Affiliates
U.S. GAAP Adjustment
Net Income Before Extra. Items
Total Extraordinary Items
Net Income
Total Adjustments to Net Income
Income Available to Com Excl ExtraOrd
Income Available to Com Incl ExtraOrd
Dilution Adjustment
Diluted Net Income
Diluted Weighted Average Shares
Diluted EPS Excluding ExtraOrd Items
Diluted EPS including ExtraOrd Items
DPS – Common Stock Primary Issue
Diluted Normalized EPS
FY 2024
31.08K
31.08K
--
--
--
42.76K
42.76K
--
--
--
--
--
-11.68K
--
--
--
-11.68K
0.00
-11.68K
--
--
--
-11.68K
--
-11.68K
--
-11.68K
-11.68K
--
-11.68K
6.45M
-0.00
-0.00
--
-0.00
FY 2023
9560.00
9560.00
--
--
--
18.39K
18.39K
--
--
--
--
--
-8830.00
--
--
--
-8830.00
0.00
-8830.00
--
--
--
-8830.00
--
-8830.00
--
-8830.00
-8830.00
--
-8830.00
6.45M
-0.00
-0.00
--
-0.00
FY 2022
5000.00
5000.00
--
--
--
19.89K
19.89K
--
--
--
--
--
-14.89K
--
--
--
-14.89K
0.00
-14.89K
--
--
--
-14.89K
--
-14.89K
--
-14.89K
-14.89K
--
-14.89K
6.38M
-0.00
-0.00
--
-0.00
FY 2021
4970.00
4970.00
--
--
--
12.53K
12.53K
--
--
--
--
--
-7560.00
--
--
--
-7560.00
0.00
-7560.00
--
--
--
-7560.00
--
-7560.00
--
-7560.00
-7560.00
--
-7560.00
5.02M
-0.00
-0.00
--
-0.00
FY 2020
0.00
0.00
--
--
--
760.00
760.00
--
--
--
--
--
-760.00
--
--
--
-760.00
0.00
-760.00
--
--
--
-760.00
--
-760.00
--
-760.00
-760.00
--
-760.00
5.00M
-0.00
-0.00
0.00
-0.00

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.